title: Upregulation of leptin-receptor in placental cells by hypoxia.
abstract: OBJECTIVE
  Leptin and its receptor (Ob-R) are co-expressed in human placenta suggesting auto- and paracrine mechanisms of the hormone. So far it is unclear, how changes in the placental environment affect Ob-R expression. Hence, the main purpose of the study was to investigate leptin receptor expression and regulation under hypoxic conditions. The influences of hypoxia and leptin on signal transduction and cell proliferation in chorioncarcinoma cell lines as well as primary villous trophoblasts were determined.
  
  
  RESULTS
  We found a time-dependent induction of leptin receptor mRNA and protein in placental cells under hypoxic conditions. In contrast, soluble leptin receptor expression did not change under oxygen deprivation. Leptin treatment neither activated the p42/p44 nor the STAT3 pathway in placental cells, being independent of hypoxic or normoxic conditions. Furthermore, leptin added to the culture medium in high concentrations was unable to interfere with the rate of proliferation.
  
  
  CONCLUSIONS
  Our data demonstrate that hypoxia leads to an increase of Ob-R expression in placental cells. Interestingly, leptin-dependent signal transduction and proliferation remained unaffected. A possible role of the soluble leptin receptor in modulating free leptin levels will be discussed.
authors.affiliation: Department of Pediatrics and Adolescent Medicine, University Erlangen-Nuernberg, Erlangen, Germany. daniela.klaffenbach@uk-erlangen.de
authors.forename: Daniela
authors.initials: D
authors.lastname: Klaffenbach
authors.forename: Udo
authors.initials: U
authors.lastname: Meissner
authors.forename: Michael
authors.initials: M
authors.lastname: Raake
authors.forename: Fabian
authors.initials: F
authors.lastname: Fahlbusch
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Alejandre Alcazar
authors.forename: Ida
authors.initials: I
authors.lastname: Allabauer
authors.forename: Jürgen
authors.initials: J
authors.lastname: Kratzsch
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Rascher
authors.forename: Jörg
authors.initials: J
authors.lastname: Dötsch
mesh_terms: D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002822:Choriocarcinoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002824:Chorionic Villi; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D000860:Hypoxia / Q000378:metabolism*; D020738:Leptin / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology*; D019950:Mitogen-Activated Protein Kinase 1 / Q000235:genetics / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000235:genetics / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D010920:Placenta / Q000166:cytology / Q000378:metabolism; D011247:Pregnancy; D012333:RNA, Messenger / Q000032:analysis; D054411:Receptors, Leptin / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050796:STAT3 Transcription Factor / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D014327:Trophoblasts / Q000166:cytology / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects; D014594:Uterine Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology
chemical_list: D020738:Leptin; D012333:RNA, Messenger; D054411:Receptors, Leptin; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D010100:Oxygen